Jonathan Sugimoto

Affiliate Assistant Professor, Epidemiology



PhD Epidemiology, University of Washington, 2010
MHS International Health, Johns Hopkins University, 2002
BS Biology, Calvin College, 2000





Jonathan Sugimoto is an Epidemiologist and Investigator with the Seattle Epidemiologic Research and Information Center (ERIC) at the United States Department of Veteran Affairs (VA) Puget Sound Health Care Medical Center, Seattle WA. The Seattle ERIC one of a network of Epidemiology Centers supported by the Cooperative Studies Program of the VA’s Office of Research and Development.

Research Interests

Dr. Jonathan Sugimoto is a quantitative infectious disease epidemiologist whose research focuses on the estimation and modeling of the burden and prevention of communicable pathogens in humans.  His research experience extends from designing, implementing, analyzing, and reporting observational field studies and randomized vaccine trials, to developing and applying statistical methods and models for reducing bias in observational/ecological studies of vaccine efficacy/effectiveness.  He has used a wide variety of statistical methods and approaches to infer and model vaccine-preventable disease burden and vaccine effects for populations that range from the very local to the global.  Jonathan also has experience applying geostatistical methods to geolocated infectious disease and nutritional epidemiologic data.  Dr. Sugimoto has conducted global health research across sub-Saharan Africa and South Asia.  Recently, Dr. Sugimoto’s work has focused on the design and analysis of studies and trial of the effectiveness of vaccines against neglected enteric diseases in low-resource tropical settings, such as typhoid, cholera, and rotavirus. 

Dr. Sugimoto recently joined the Seattle Epidemiologic Research and Information Center (VA Puget Sound Health Care System), where he is an investigator with several SARS-CoV-2/COVID-19 related projects, including serving as the Program Director for a national prospective cohort study (CSP #2028) of the natural history, immune response, transmission, and clinical outcomes of symptomatic SARS-CoV-2 infection among Veteran-users of the VA health care system.

Recent Publications (PubMed)

Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics.
(2021 Mar 19)
Vaccines (Basel) 9(3):
Haselbeck AH, Tadesse BT, Park J, Gibani MM, Espinoza LMC, Abreu A, Van Rensburg C, Owusu-Ansah M, Twuamsi-Ankrah S, Owusu M, Aguna I, Picot V, Jeon H, Higginson E, Park S, Mojares ZR, Im J, Carey ME, Khanam F, Tonks S, Dougan G, Kim D, Sugimoto J, Mogasale V, Neuzil KM, Qadri F, Adu-Sarkodie Y, Owusu-Dabo E, Clemens J, Marks F

Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011.
(2020 Nov 9)
Clin Infect Dis
Niang MN, Sugimoto JD, Diallo A, Diarra B, Ortiz JR, Lewis KDC, Lafond KE, Halloran ME, Widdowson MA, Neuzil KM, Victor JC

Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.
(2020 Aug)
Lancet Glob Health 8(8): e1081-e1089
Lee EC, Chao DL, Lemaitre JC, Matrajt L, Pasetto D, Perez-Saez J, Finger F, Rinaldo A, Sugimoto JD, Halloran ME, Longini IM Jr, Ternier R, Vissieres K, Azman AS, Lessler J, Ivers LC

Networks of face-to-face social contacts in Niakhar, Senegal.
PLoS One 14(8): e0220443
Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME

Reply to Skowronski and De Serres.
(2019 Nov 27)
Clin Infect Dis 69(12): 2231-2232
Ortiz JR, Sugimoto JD, Neuzil KM, Halloran ME, Victor JC

Show complete publication list

In the News

No news articles at this time.